Ascendis Pharma
ASND
ASND
143 hedge funds and large institutions have $6.42B invested in Ascendis Pharma in 2019 Q4 according to their latest regulatory filings, with 36 funds opening new positions, 50 increasing their positions, 46 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
7% more funds holding in top 10
Funds holding in top 10: 14 → 15 (+1)
9% more repeat investments, than reductions
Existing positions increased: 50 | Existing positions reduced: 46
0.33% less ownership
Funds ownership: 97% → 96.67% (-0.33%)
Holders
143
Holding in Top 10
15
Calls
$102M
Puts
$26.4M
Top Buyers
| 1 | +$129M | |
| 2 | +$128M | |
| 3 | +$44.7M | |
| 4 |
Westfield Capital Management
Boston,
Massachusetts
|
+$19M |
| 5 |
Bank of New York Mellon
New York
|
+$18.7M |
Top Sellers
| 1 | -$72.6M | |
| 2 | -$59.2M | |
| 3 | -$52.3M | |
| 4 |
MWNA
Marshall Wace North America
New York
|
-$49.7M |
| 5 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$37.7M |